Jay Norman Cohn
#52,450
Most Influential Person Now
Jay Norman Cohn's AcademicInfluence.com Rankings
Jay Norman Cohnmedical Degrees
Medical
#319
World Rank
#463
Historical Rank
Cardiology
#7
World Rank
#7
Historical Rank
Jay Norman Cohnphilosophy Degrees
Philosophy
#1667
World Rank
#2983
Historical Rank
Logic
#269
World Rank
#560
Historical Rank
Download Badge
Medical Philosophy
Why Is Jay Norman Cohn Influential?
(Suggest an Edit or Addition)Jay Norman Cohn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. (1991) (7693)
- The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. (1996) (3965)
- Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. (1992) (3699)
- Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. (1984) (3153)
- A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. (1991) (2732)
- The effect of digoxin on mortality and morbidity in patients with heart failure. (1997) (2495)
- A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. (2001) (2336)
- Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. (2000) (2331)
- Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. (1986) (1910)
- Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. (2004) (1595)
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study (1987) (1108)
- Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. (1992) (950)
- Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) (2003) (855)
- Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure (1993) (704)
- Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure (2007) (692)
- Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. (1983) (692)
- Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. (1996) (667)
- Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. (1982) (638)
- Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study (2003) (637)
- The neurohumoral axis in congestive heart failure. (1984) (622)
- Right ventricular infarction. Clinical and hemodynamic features. (1974) (582)
- Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. (1988) (567)
- Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. (1985) (535)
- Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. (2001) (534)
- Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. (1993) (506)
- Noninvasive pulse wave analysis for the early detection of vascular disease. (1995) (496)
- Plasma Norepinephrine, Plasma Renin Activity, and Congestive Heart Failure Relations to Survival and the Effects of Therapy in V‐HeFT II (1993) (490)
- Increased plasma arginine vasopressin levels in patients with congestive heart failure. (1983) (484)
- From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report (2006) (475)
- Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. (1999) (467)
- Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). (2005) (428)
- A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure (1998) (427)
- C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan (2005) (427)
- Vasodilator Therapy of Cardiac Failure (1977) (412)
- The Influence of Atrial Fibrillation on Prognosis in Mild to Moderate Heart Failure The V‐HeFT Studies (1993) (405)
- Role of the Renin-Angiotensin System in the Systemic Vasoconstriction of Chronic Congestive Heart Failure (1978) (397)
- Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
- Prognostic Significance of Serial Changes in Left Ventricular Ejection Fraction in Patients With Congestive Heart Failure (1993) (385)
- Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. (1999) (375)
- The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. (2004) (374)
- The autonomic nervous system and heart failure. (2014) (373)
- Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. (2002) (354)
- Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. (2006) (352)
- Treatment of refractory heart failure with infusion of nitroprusside. (1974) (343)
- Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON) (2003) (341)
- IMPROVED LEFT VENTRICULAR FUNCTION DURING NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTION (1972) (333)
- Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. (1990) (331)
- Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial (2004) (329)
- Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. (1997) (317)
- Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). (2008) (314)
- Effects of Valsartan on Circulating Brain Natriuretic Peptide and Norepinephrine in Symptomatic Chronic Heart Failure: The Valsartan Heart Failure Trial (Val-HeFT) (2002) (312)
- Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. (1995) (310)
- Vascular compliance and cardiovascular disease: a risk factor or a marker? (1997) (298)
- Surrogate Markers for Cardiovascular Disease: Functional Markers (2004) (296)
- Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. (2001) (286)
- New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. (2000) (280)
- Anemia and Change in Hemoglobin Over Time Related to Mortality and Morbidity in Patients With Chronic Heart Failure: Results From Val-HeFT (2005) (274)
- Acute and Long‐term Response to an Oral Converting‐enzyme Inhibitor, Captopril, in Congestive Heart Failure (1980) (271)
- Incidence of Thromboembolic Events in Congestive Heart Failure (1993) (269)
- Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure: Relation to Disease Severity and Prognosis in the Valsartan Heart Failure Trial (2010) (265)
- Vasodilator Therapy for Heart Failure: The Influence of Impedance on Left Ventricular Performance (1973) (260)
- Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure (1974) (259)
- Prognosis of congestive heart failure and predictors of mortality. (1988) (257)
- From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. (2006) (251)
- Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. (1982) (237)
- Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. (2002) (232)
- Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. (1997) (223)
- Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. (1994) (222)
- Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Vasodilator Heart Failure Trial (V-HeFT) Study Group. (1999) (219)
- Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. (1977) (218)
- Safety and efficacy of carvedilol in severe heart failure (1997) (215)
- Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure: Data From 2 Large Randomized Clinical Trials (2012) (214)
- Vasodilator therapy of cardiac failure (second of two parts). (1977) (210)
- Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data. (2004) (209)
- Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. (2003) (200)
- Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. (1999) (192)
- Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. (1982) (190)
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals (2011) (189)
- Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. (1998) (188)
- Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document (2013) (183)
- The management of chronic heart failure. (1996) (182)
- Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. (1987) (181)
- Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. (1982) (180)
- Hemodynamic effect of dobutamine in patients with severe heart failure. (1975) (175)
- Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. (1980) (174)
- Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. (1995) (174)
- Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. (1982) (172)
- Neurohumoral control mechanisms in congestive heart failure. (1981) (171)
- Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. (1972) (162)
- Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion. (1967) (160)
- Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. (1980) (153)
- Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. (2005) (153)
- Mechanism of Death in Heart Failure The Vasodilator‐Heart Failure Trials (1993) (152)
- Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. (1999) (151)
- Reduced vascular compliance as a marker for essential hypertension. (1991) (148)
- Baseline and serial measurements of galectin‐3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val‐HeFT (2013) (147)
- Arterial stiffness as a risk factor for coronary atherosclerosis (2007) (145)
- Blood pressure measurement in shock. Mechanism of inaccuracy in ausculatory and palpatory methods. (1967) (144)
- Definition and Classification of Hypertension: An Update (2009) (143)
- Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life. (2006) (140)
- A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. (1985) (140)
- Expanding the Definition and Classification of Hypertension (2005) (140)
- Vascular wall function as a risk marker for cardiovascular disease. (1999) (138)
- Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. (2007) (136)
- Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. (1978) (135)
- First- and third-order models for determining arterial compliance. (1992) (133)
- Nitrate Therapy for Congestive Heart Failure (1978) (133)
- Prognostic application of arterial stiffness: task forces. (2002) (133)
- The Neurohumoral and Hemodynamic Response to Orthostatic Tilt in Patients with Congestive Heart Failure (1983) (133)
- Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. (1984) (130)
- Left ventricular function in acute myocardial infarction. (1971) (130)
- Incremental prognostic value of changes in B-type natriuretic peptide in heart failure. (2006) (128)
- Cardiac and peripheral vascular effects of digitalis in clinical cardiogenic shock. (1969) (128)
- Arterial stiffness, vascular disease, and risk of cardiovascular events. (2006) (128)
- Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. (1993) (125)
- Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. (1996) (125)
- Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure. (1985) (124)
- Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure. (1983) (124)
- Effects of long-term cigarette smoking on endothelium-dependent responses in humans. (1996) (124)
- Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. (1987) (123)
- Echocardiographic Variables as Prognostic Indicators and Therapeutic Monitors in Chronic Congestive Heart Failure Veterans Affairs Cooperative Studies V‐HeFT I and II (1993) (123)
- Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy (2004) (122)
- Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis (2018) (121)
- Comparative Hemodynamic Effects of Inotropic and Vasodilator Drugs in Severe Heart Failure (1977) (121)
- Determinants of radial artery pulse wave analysis in asymptomatic individuals. (2004) (121)
- Proteinuria, Chronic Kidney Disease, and the Effect of an Angiotensin Receptor Blocker in Addition to an Angiotensin-Converting Enzyme Inhibitor in Patients With Moderate to Severe Heart Failure (2009) (120)
- Effect of dilation of the distal coronary bed on flow and resistance in severely stenotic coronary arteries in the dog. (1979) (120)
- Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease. (1972) (120)
- Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure. (1983) (116)
- Impaired Left Ventricular Function in Alcoholic Cirrhosis With Ascites: Ineffectiveness of Ouabain (1974) (113)
- Hemodynamic effects of infused arginine vasopressin in congestive heart failure. (1986) (113)
- Prognostic Value of Soluble ST2 in the Valsartan Heart Failure Trial (2014) (113)
- Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val‐HeFT (2004) (113)
- Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention. (1993) (112)
- Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. (1993) (112)
- Regional differences in adrenergic function within the left ventricle. (1984) (111)
- Right ventricular infarction revisited. (1979) (110)
- Blood pressure and cardiac performance. (1973) (110)
- Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure. (1978) (110)
- Relationship between C-reactive protein and arterial stiffness in an asymptomatic population (2005) (109)
- Ventricular remodeling in heart failure: a credible surrogate endpoint. (2003) (108)
- sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T. (2018) (108)
- Relative Effects of α1‐Adrenoceptor Blockade, Converting Enzyme Inhibitor Therapy, and Angiotensin II Subtype 1 Receptor Blockade on Ventricular Remodeling in the Dog (1994) (106)
- Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention (1990) (106)
- Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI‐HF and Val‐HeFT trials (2015) (105)
- Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. (2001) (104)
- Vascular abnormalities associated with long-term cigarette smoking identified by arterial waveform analysis. (1997) (103)
- Hemodynamic Effects of Labetalol, an Alpha and Beta Adrenergic Blocking Agent, in Hypertensive Subjects (1977) (103)
- Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure. (1974) (101)
- Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technic. (1972) (100)
- Predominant right ventricular dysfunction after right ventricular destruction in the dog. (1974) (100)
- Studies in clinical shock and hypotension: VI. Relationship between left and right ventricular function. (1969) (99)
- Early and Sustained Benefit on Event-Free Survival and Heart Failure Hospitalization From Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine: Consistency Across Subgroups in the African-American Heart Failure Trial (2007) (99)
- Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
- Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
- African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology. (2002) (98)
- Comparison of Effects of Angiotensin and Norepinephrine on Pulmonary Circulation, Systemic Arteries and Veins, and Systemic Vascular Capacity in the Dog (1962) (98)
- Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial. (2006) (97)
- Early Redistribution of Thallium‐201 after Temporary Ischemia (1978) (97)
- The prevention of heart failure--a new agenda. (1992) (96)
- Enalapril Decreases Prevalence of Ventricular Tachycardia in Patients With Chronic Congestive Heart Failure (1993) (96)
- Current therapy of the failing heart. (1988) (96)
- The autonomic nervous system in congestive heart failure. (1986) (94)
- Effects of Sustained-Release Moxonidine, an Imidazoline Agonist, on Plasma Norepinephrine in Patients With Chronic Heart Failure (2002) (93)
- Comparative Hemodynamic Effects of Chewable Isosorbide Dinitrate and Nitroglycerin in Patients with Congestive Heart Failure (1975) (90)
- Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial (2007) (90)
- Calculated plasma volume status and prognosis in chronic heart failure (2015) (90)
- Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment. (2005) (89)
- Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker Valsartan in Patients With Chronic Heart Failure: Results From the Valsartan Heart Failure Trial (2003) (89)
- Arterial Vascular Compliance Response to Vasodilators by Fourier and Pulse Contour Analysis (1988) (89)
- Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes (2017) (89)
- Introduction to surrogate markers. (2004) (88)
- Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. (1994) (88)
- Response of vasopressin and norepinephrine to lower body negative pressure in humans. (1982) (88)
- High resolution proton NMR studies of perfused rat hearts (1984) (87)
- Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial. (2007) (87)
- Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure. (1979) (85)
- Effect of Coronary Arterial Pressure on Coronary Stenosis Resistance (1980) (85)
- Functional Capacity in Heart Failure Comparison of Methods for Assessment and Their Relation to Other Indexes of Heart Failure (1993) (83)
- STUDIES IN CLINICAL SHOCK AND HYPOTENSION. II. HEMODYNAMIC EFFECTS OF NOREPINEPHRINE AND ANGIOTENSIN. (1965) (82)
- HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America. (2000) (81)
- Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT) (1996) (81)
- Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival Results From the Valsartan Heart Failure Trial (2016) (80)
- Effect of Salt on the Vascular Lesions of Spontaneously Hypertensive Rats (1980) (79)
- Abnormalities of peripheral sympathetic nervous system control in congestive heart failure. (1990) (78)
- The Sympathetic Nervous System in Heart Failure (2002) (78)
- Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial. (2009) (78)
- Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT. (2007) (78)
- Circulation times in the splanchnic and hepatic beds in alcoholic liver disease. (1972) (77)
- Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT. (2007) (76)
- 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 4. Efficacy of risk factor management. (1996) (76)
- Effect of captopril on renal function in patients with congestive heart failure. (1981) (75)
- The effects of bromocriptine in patients with congestive heart failure. (1983) (75)
- Hydralazine and Isosorbide Dinitrate Combination Improves Exercise Tolerance in Heart Failure Results from V‐HeFT I and V‐HeFT II (1993) (74)
- Blood pressure and arterial compliance in young adults: the Minnesota Children's Blood Pressure Study. (2001) (73)
- Arterial compliance abnormalities in isolated systolic hypertension. (2001) (72)
- Endothelial dysfunction and the metabolic syndrome (2003) (72)
- Effect of Enalapril, Hydralazine Plus Isosorbide Dinitrate, and Prazosin on Hospitalization in Patients With Chronic Congestive Heart Failure (1993) (71)
- Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure. (1978) (71)
- Hyponatraemia as a marker for high renin heart failure. (1982) (70)
- Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group. (2001) (70)
- Regional blood flow response to orthostasis in patients with congestive heart failure. (1983) (70)
- Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure. (1986) (69)
- Defective Calcium Transport by Cardiac Sarcoplasmic Reticulum in Spontaneously Hypertensive Rats (1977) (69)
- Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. (2007) (68)
- Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT). (2010) (68)
- Hemodynamic, left ventricular structural and hormonal changes after discrete myocardial damage in the dog. (1992) (68)
- Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. (1990) (68)
- Ventricular dimensions measured noninvasively by echocardiography in the awake dog. (1976) (68)
- The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT). (2006) (67)
- Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies. (2000) (65)
- Effects of vasodilators on pulmonary hemodynamics and gas exchange in left ventricular failure. (1980) (65)
- Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology. (2006) (65)
- Outcomes by gender in the African-American Heart Failure Trial. (2006) (65)
- Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog. (1993) (64)
- A comparison of enalapril with hydrazaline-isosorbide dinitrate in the treatment of chronic congestive heart failure (1991) (64)
- Beneficial Effects of Pimobendan on Exercise Tolerance and Qualit of Life in Patients With Heart Failure: Results of a Multicenter Trial (1992) (63)
- Sequential neurohumoral measurements in patients with congestive heart failure. (1988) (63)
- Evolution of Abnormalities in Left Ventricular Function after Acute Myocardial Infarction (1972) (62)
- Effects of Minoxidil on Hemodynamics in Patients with Congestive Heart Failure (1981) (62)
- Screening for early detection of cardiovascular disease in asymptomatic individuals. (2003) (62)
- Abnormalities of vascular compliance in hypertension, aging and heart failure (1992) (62)
- TREATMENT OF REFRACTORY HEART FAILURE WITH INFUSION OF NITROPRUSSIDE (1975) (59)
- Rapid, accurate and simultaneous noninvasive assessment of right and left ventricular mass with nuclear magnetic resonance imaging using the snapshot gradient method. (1992) (59)
- Mechanism of pulsus paradoxus in clinical shock. (1967) (59)
- The Arterial System in Human Hypertension (2007) (58)
- Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. (1997) (58)
- Effect of valsartan on quality of life when added to usual therapy for heart failure: results from the Valsartan Heart Failure Trial. (2005) (58)
- Plasma norepinephrine and mortality (1995) (58)
- Increased renal plasma flow in long‐term enalapril treatment of hypertension (1983) (58)
- Vascular hemodynamic impedance in congestive heart failure. (1985) (57)
- Interaction between baseline and early worsening of renal function and efficacy of renin–angiotensin–aldosterone system blockade in patients with heart failure: insights from the Val‐HeFT study (2013) (56)
- Selection of vasodilator, inotropic or combined therapy for the management of heart failure. (1978) (56)
- Baseline demographics of the Valsartan Heart Failure Trial (2000) (55)
- Hemodynamic effects of nifedipine at rest and during exercise in primary pulmonary hypertension. (1984) (55)
- Effect of Valsartan on hospitalization: results from Val-HeFT. (2003) (55)
- Non-invasive studies of peripheral vascular compliance using a non-occluding photoplethysmographic method (1998) (55)
- Central venous pressure as a guide to volume expansion. (1967) (55)
- Neuroendocrine activation after acute myocardial infarction. (1990) (55)
- Ventricular myocardial catecholamines in primates. (1985) (55)
- Stimulation of Vascular Smooth Muscle Sodium, Potassium—Adenosinetriphosphatase by Vasodilators (1974) (55)
- Nitrate therapy for congestive heart failure. (1978) (54)
- Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin-A Receptor Antagonist Trial in heart failure (EARTH): Randomised, double-blind, placebo-controlled trial (2004) (53)
- STUDIES IN CLINICAL SHOCK AND HYPOTENSION; THE VALUE OF BEDSIDE HEMODYNAMIC OBSERVATIONS. (1964) (53)
- Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure. (1987) (52)
- Postsynthetic variants of creatine kinase MM. (1981) (52)
- The first report of the Systolic and Pulse Pressure (SYPP) Working Group. (1999) (51)
- Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial. (2009) (51)
- The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction. (1993) (50)
- The effectiveness of cardiology consultation. Concordance with diagnostic and drug recommendations. (1981) (50)
- Hemodynamic effects of trimazosin in patients with left ventricular failure (1978) (49)
- Hemodynamic Effects of Guanethidine in Man (1963) (49)
- Pathophysiologic aspects of end-stage heart failure. (1995) (49)
- Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure. (1981) (48)
- Time to foster a rational approach to preventing cardiovascular morbid events. (2008) (48)
- Comparative Cardiovascular Effects of Tyramine, Ephedrine, and Norepinephrine in Man (1965) (48)
- Digoxin use and heart failure outcomes: results from the Valsartan Heart Failure Trial (Val-HeFT). (2010) (47)
- Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial (2017) (47)
- Direct‐Acting Vasodilators (2011) (46)
- Isolation and properties of myocardial prostaglandin synthetase. (1973) (46)
- Positive inotropic effect of oral esproquin in normal subjects (1973) (46)
- A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure. (1992) (46)
- Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study. (2007) (45)
- Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy. (1983) (45)
- Interobserver discordance in the classification of mechanisms of death in studies of heart failure. (1995) (45)
- Inotropic therapy for heart failure: paradise postponed. (1989) (45)
- HFSA 2010 Guideline Executive Summary Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline (2006) (44)
- Bradycardia with mitral valve prolapse: a potential mechanism of sudden death. (1976) (44)
- Studies in Clinical Shock and Hypotension: V. Hemodynamic Effects of Dextran (1967) (44)
- M-mode and two-dimensional echocardiographic analysis of the septum in experimental right ventricular infarction: correlation with hemodynamic alterations. (1985) (44)
- Comparative effects of saline and mannitol on renal cortical blood flow and volume in the dog. (1973) (44)
- Critical review of heart failure: The role of left ventricular remodeling in the therapeutic response–Cohn: Remodeling in heart failure (1995) (43)
- Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart. (1979) (43)
- Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group. (1993) (42)
- Marked spontaneous improvement in ejection fraction in patients with congestive heart failure. (1990) (42)
- Calcium, vascular smooth muscle, and calcium entry blockers in hypertension. (1983) (42)
- Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure. (1984) (42)
- Effect of Hydralazine on Renal Failure in Patients with Congestive Heart Failure (1980) (40)
- Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure. (1980) (40)
- Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT). (2004) (40)
- Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial (2008) (40)
- Evaluation by Patients With Heart Failure of the Effects of Enalapril Compared With Hydralazine Plus Isosorbide Dinitrate on Qualit of Life V‐HeFT II (1993) (40)
- Pathophysiologic and prognostic implications of measuring arterial compliance in hypertensive disease. (1999) (40)
- Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure. (1982) (39)
- G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT. (2014) (39)
- Effect of the Angiotensin Receptor Blocker Valsartan on Morbidity and Mortality in Heart Failure: the Valsartan Heart Failure Trial (Val-HeFT) (2000) (39)
- Physiologic basis of vasodilator therapy for heart failure. (1981) (38)
- Influence of Age on Mechanisms and Prognosis of Heart Failure (1993) (38)
- Bedside catheterization of the left ventricle. (1970) (38)
- Vasodilator therapy of cardiac failure: (first of two parts). (1977) (38)
- Systemic Vasoconstrictor and Renal Vasodilator Effects of PLV‐2 (Octapressin) in Man (1968) (38)
- Antihypertensive Utility of Perindopril in a Large, General Practice‐Based Clinical Trial (2004) (37)
- Improving Outcomes in Congestive Heart Failure: Val-HeFT (1999) (37)
- Role of nitric oxide deficiency and its detection as a risk factor in pre-hypertension. (2007) (37)
- Effect of carvedilol in severe chronic heart failure (1996) (37)
- Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. (1994) (36)
- The Importance of Arterial Compliance in Cardiovascular Drug Therapy (1998) (35)
- Safety of graded symptom-limited exercise testing in patients with congestive heart failure. (1987) (35)
- Pressure pulse contour analysis in determining the effect of vasodilator drugs on vascular hemodynamic impedance characteristics in dogs. (1980) (35)
- Prognostic factors in heart failure: Poverty amidst a wealth of variables (1989) (35)
- Arteries, myocardium, blood pressure and cardiovascular risk: towards a revised definition of hypertension. (1998) (34)
- Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality? (2009) (34)
- Serial Serum Creatine Phosphokinase MB Isoenzyme Activity after Myocardial Infarction: Studies in the Baboon and Man (1977) (34)
- Angiotensin-converting enzyme inhibition in congestive heart failure: the concept. (1982) (34)
- Hemodynamic and regional blood flow response to captopril in congestive heart failure. (1984) (34)
- Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia. (2009) (34)
- Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction. (1994) (33)
- Changes inβ-actin mRNA Expression in Remodeling Canine Myocardium (1996) (33)
- Effect of increased intracardiac and arterial pressure on plasma vasopressin in humans. (1984) (33)
- Prognosis in congestive heart failure. (1994) (33)
- Progressive myocardial dysfunction associated with increased vascular resistance. (1980) (32)
- Effects of coronary occlusion on flow in the distribution of a neighboring stenotic coronary artery in the dog. (1983) (32)
- Normalization of sympathetic nervous system function after orthotopic cardiac transplant in man. (1987) (32)
- Arterial stiffness [2] (1999) (32)
- Nitrates for congestive heart failure. (1985) (32)
- Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure. (1986) (31)
- Relationship between periventricular or deep white matter lesions and arterial elasticity indices in very old people. (2001) (31)
- Clinical and Hemodynamic Features (1974) (31)
- Monitoring vascular health beyond blood pressure (2006) (30)
- The Use of Race and Ethnicity in Medicine: Lessons from the African-American Heart Failure Trial (2006) (29)
- Is there a role for endothelin in the natural history of heart failure? (1996) (29)
- Relationship between arterial elasticity indices and carotid artery intima-media thickness. (2000) (28)
- Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome (2019) (28)
- Hypertension and the heart. (1974) (28)
- Alpha 2-receptor-mediated vasoconstriction in patients with congestive heart failure. (1989) (28)
- Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failure. (1989) (28)
- Impaired response of plasma vasopressin to orthostatic stress in patients with congestive heart failure. (1983) (28)
- Superiority of Dobutamine over Dopamine for Augmentation of Cardiac Output in Patients with Chronic Low Output Cardiac Failure (28)
- HFSA guidelines for the management of patients with heart failure due to left ventricular systolic dysfunction--pharmacological approaches. (2000) (28)
- New therapeutic strategies for heart failure: left ventricular remodeling as a target. (2004) (27)
- Identifying Early Cardiovascular Disease to Target Candidates for Treatment (2008) (27)
- Short‐Term Systemic Hemodynamic Adaptation to Beta‐Adrenergic Inhibition with Atenolol in Hypertensive Patients (1981) (27)
- Influence of Prerandomization (Baseline) Variables on Mortalit and on the Reduction of Mortalit by Enalapril Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V‐HeFT II) (1993) (27)
- Splanchnic hemodynamics in cirrhotic patients with esophageal varices and gastrointestinal bleeding. (1976) (27)
- The African-American Heart Failure Trial: background, rationale and significance. (2002) (26)
- Myocardial damage after repetitive direct current shock in the dog: correlation between left ventricular end-diastolic pressure and extent of myocardial necrosis. (1978) (26)
- Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations. (2011) (26)
- Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. (2001) (26)
- Role of the Renin-Angiotensin System in Cardiovascular Disease (2010) (26)
- Early ventricular remodeling after myocardial damage and its attenuation by converting enzyme inhibition. (1990) (26)
- Cardiac protection: evolving role of angiotensin receptor blockers. (2000) (26)
- Learned precise cardiovascular control through graded central sympathetic stimulation. (1984) (25)
- ACE inhibition and vascular remodeling of resistance vessels: vascular compliance and cardiovascular implications. (2000) (25)
- Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial. (2004) (25)
- Hepatic lobar distribution of splenic and mesenteric blood flow in man. (1971) (25)
- Optimal diuretic therapy for heart failure. (2001) (24)
- Mechanism of exercise hypotension after sympathetic blockade. (1970) (24)
- The angiotensin receptor blockers. (1999) (24)
- Cardiac failure: a revised paradigm. (1995) (24)
- High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. (2019) (24)
- Effect of vasodilator therapy on mortality in chronic congestive heart failure. (1988) (24)
- Overview of the treatment of heart failure. (1997) (24)
- Norepinephrine infusions in congestive heart failure. (1985) (23)
- SCIENTIFIC LANGUAGE (2000) (23)
- Decreased Venous Distensibility in Essential Hypertension: Lack of Systemic Hemodynamic Correlates (1979) (23)
- Systolic Time Intervals and Left Ventricular Function in Acute Myocardial Infarction (1972) (23)
- Studies in Clinical Shock and Hypotension: VII. Renal Hemodynamics Before and During Treatment (1970) (23)
- Contrasting acute and chronic effects of nitrates on exercise capacity in heart failure (1979) (22)
- High renin in heart failure: a manifestation of hyponatremia. (1979) (22)
- Vasodilator Therapy of Myocardial Infarction (1974) (22)
- Clinical and analytical considerations in the study of health status in device trials for heart failure. (2005) (22)
- The sympathetic nervous system in heart failure. (1989) (22)
- Arterial pressure as a determinant of left ventricular filling pressure after acute myocardial infarction. (1974) (22)
- New approaches to screening for vascular and cardiac risk. (2001) (21)
- A nonsurgical canine model of chronic left ventricular myocardial dysfunction. (1983) (21)
- Intrahepatic distribution of hepatic arterial and portal venous flows in the dog. (1969) (21)
- Left ventricle and arteries: structure, function, hormones, and disease. (2001) (21)
- Free and conjugated plasma catecholamines in patients with congestive heart failure. (1984) (21)
- Effect of delayed intervention with ACE-inhibitor therapy on myocyte hypertrophy and growth of the cardiac interstitium in the rat model of myocardial infarction. (1997) (20)
- Exercise-induced decrease in flow through stenotic coronary arteries in the dog. (1982) (20)
- Contrasting effect of vasodilators on heart rate and plasma catecholamines in patients with hypertension and heart failure (1978) (20)
- Renal vasodilator therapy in the hepatorenal syndrome. (1970) (20)
- Indications for digitalis therapy. A new look. (1974) (20)
- A review of the haemodynamic effects of labetalol in man. (1982) (20)
- Decline in blood flow in stenotic coronary arteries during increased myocardial energetic demand in response to pacing-induced tachycardia. (1981) (20)
- Alkaline phosphatase in vascular smooth muscle. (1973) (20)
- Unilateral renal hemodynamics studied by an indicator-dilution technic in man. (1965) (20)
- Left and right ventricular dimensions during ventricular fibrillation in the dog. (1978) (20)
- Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T (2020) (20)
- Erratum: Mild systolic dysfunction in heart failure (left ventricular ejection fraction > 35%): Baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT) (J Am Coll Cardiol (1996), 27:642-9) (1996) (19)
- An interdisciplinary comparison of consultation outcomes. Psychiatry vs cardiology. (1981) (19)
- Hemodynamic improvement with hydralazine in left heart failure (1976) (19)
- Reducing cardiovascular risk by blockade of the renin-angiotensin-aldosterone system (2007) (19)
- Effect of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine on All Hospitalizations and on 30-Day Readmission Rates in Patients With Heart Failure: Results From the African-American Heart Failure Trial (2014) (19)
- Structural changes in cardiovascular disease. (1995) (19)
- Effects of ACE Inhibitors or ↓-Blockers in Patients Treated with the Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial (2007) (18)
- Influence of cortical plasma transit-time on p-aminohippurate extraction during induced renal vasodilatation in anaesthetized dogs. (1972) (18)
- Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction. (2012) (18)
- Acute Hemodynamic and Hormonal Effects of Central Versus Peripheral Sympathetic Inhibition in Patients with Congestive Heart Failure (1986) (18)
- The acute response of plasma norepinephrine, renin activity, and arginine vasopressin to short-term nitroprusside and nitroprusside withdrawal in patients with congestive heart failure. (1983) (18)
- Task force 2: Investigator participation in clinical research. (2004) (18)
- Renal hemodynamic alterations in liver disease. (1976) (18)
- Lack of Bioequivalence between Different Formulations of Isosorbide Dinitrate and Hydralazine and the Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine (2007) (18)
- Effect of head-down tilt on basal plasma norepinephrine and renin activity in humans. (1985) (18)
- Splanchnic hemodynamic factors in cirrhosis with refractory ascites. (1979) (18)
- Renal Cortical Blood Flow, Cortical Fraction, and Cortical Blood Volume in Hypertensive Subjects (1973) (17)
- Contemporary treatment of heart failure: Is there adequate evidence to support a unique strategy for African-Americans? pro position (2002) (17)
- Assessment of arterial compliance in hypertension. (1993) (17)
- Diagnostic and therapeutic value of bedside monitoring of left ventricular pressure (1969) (17)
- Post‐MI remodeling (1993) (17)
- Cardiac and hormonal effects of enalapril in hypertension (1983) (17)
- Rationale and design of the third Vasodilator-Heart Failure Trial (V-HeFT III): Felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure☆ (1996) (17)
- Is it the blood pressure or the blood vessel? (2007) (17)
- Progress in vasodilator therapy for heart failure. (1980) (16)
- Studies in clinical shock and hypotension. 3. Comparative effects of vasopressor drugs and dextran. (1965) (16)
- Studies in Clinical Shock and Hypotension IV. Variations in Reflex Vasoconstriction and Cardiac Stimulation (1966) (16)
- Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial. (2008) (16)
- Angiotensin converting enzyme inhibitors in congestive heart failure. Overview in comparison of captopril and enalapril. (1986) (15)
- Evidence-based medicine: what is the evidence? (1996) (15)
- Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial. (2012) (15)
- Dissociation of the responses of the renin-angiotensin system and sympathetic nervous system to a vasodilator stimulus in congestive heart failure. (1986) (15)
- NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories. (2021) (15)
- Cutaneous Administration of Nitroglycerin: A Review (1983) (15)
- Establishing a new option for target-organ protection: rationale for ARB plus ACE inhibitor combination therapy. (2008) (15)
- Identifying the risk and preventing the consequences of cardiovascular disease. (2013) (15)
- New inotropic drugs for heart failure. (1987) (15)
- Monitoring techniques in shock. (1970) (15)
- Sympathetic nervous system activity and the heart. (1989) (15)
- Hemodynamic effects of oral ephedrine given alone or combined with nitroprusside infusion in patients with severe left ventricular failure. (1979) (15)
- Heart failure in 2013: Continue what we are doing to treat HF, but do it better (2014) (14)
- Impedance cardiography: The failure of sternal electrodes to predict changes in stroke volume (1993) (14)
- Equivalent hemodynamic effects on nitroprusside and hydralazine nitrate combination in left ventricular failure (1976) (14)
- Efficacy and safety in clinical trials in cardiovascular disease. (2006) (14)
- Effect of dobutamine on plasma potassium in congestive heart failure secondary to idiopathic or ischemic cardiomyopathy. (1989) (14)
- Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Conclusions from a joint WHO/ISH meeting. (1992) (14)
- Comprehensive noninvasive arterial vascular evaluation. (2009) (14)
- Comparative haemodynamic and metabolic effects of vasodilator and inotropic agents in experimental myocardial infarction. (1978) (14)
- Task force IV: Pharmacologie interventions (1982) (14)
- Valsartan in heart failure trial (Val-HeFT) (1998) (14)
- Felodipine improves left ventricular emptying in patients with chronic heart failure: V-HeFT III echocardiographic substudy of multicenter reproducibility and detecting functional change. (2000) (14)
- Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial. (2017) (14)
- Regulation of Myocardial Prostaglandin Dehydrogenase Activity. The Role of Cyclic 3′,5′-AMP and Calcium Ions (1973) (14)
- Reflex control of osmotically stimulated vasopressin in normal humans. (1985) (13)
- Effects of A1 adenosine receptor agonism using N6-cyclohexyl-2'-O-methyladenosine in patients with left ventricular dysfunction. (1996) (13)
- Measuring endothelial function (2006) (12)
- Cortical blood flow, cortical fraction, and cortical blood volume in the dog kidney. (1971) (12)
- Changes in beta-actin mRNA expression in remodeling canine myocardium. (1996) (12)
- Orthostatic hypoxemia in a patient with bronchogenic carcinoma. (1974) (12)
- Atrial Natriuretic Factor Attenuates Sympathetic Reflexes During Lower Body Negative Pressure in Normal Men (1990) (12)
- Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure. (1994) (12)
- Dobutamine: selective inotropic action in patients with heart failure (1973) (12)
- Lessons learned from the valsartan- heart failure trial (Val-HeFT): angiotensin receptor blockers in heart failure. (2002) (12)
- Clinical implications of the hemodynamic effects of beta blockade. (1985) (12)
- Role of nitrates in congestive heart failure. (1987) (12)
- Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study (2013) (12)
- Functional impact of an increase in ventricular mass after myocardial damage and its attenuation by converting enzyme inhibition. (1998) (12)
- Calcium Entry Blockers in Coronary Artery Disease (1985) (11)
- Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort study (2017) (11)
- Mechanisms in heart failure and the role of angiotensin-converting enzyme inhibition. (1990) (11)
- β-Blockers for heart failure (2003) (11)
- Cardiovascular Disease Progression: A Target for Therapy? (2018) (11)
- Unloading the heart in congestive heart failure. (1984) (11)
- Jugular venous pressure monitoring: a lost art? (1997) (11)
- Signs and symptoms in chronic heart failure: Relevance of clinical trial results to point of care—data from Val‐HeFT (2006) (11)
- B003: Differences in large and small artery response to acute inhibition of nitric oxide synthase in human subjects (2000) (10)
- Right ventricular infarction: clinical and pathophysiologic considerations. (1988) (10)
- Remodeling as an End-Point in Heart Failure Therapy (2004) (10)
- Calcium antagonists and left ventricular function: effects of nitrendipine in congestive heart failure. (1986) (10)
- Comparative hemodynamic effects of nitroglycerin forms in heart failure (1975) (10)
- The fallacy of the mean. (2001) (10)
- Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure. (1991) (10)
- Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data (2021) (10)
- Myocardial structural effects of aldosterone receptor antagonism in heart failure. (2007) (10)
- Mechanisms of action and efficacy of nitrates in heart failure. (1992) (10)
- Plasma norepinephrine and atrial natriuretic peptide in heart failure: influence of felodipine in the third Vasodilator Heart Failure Trial. V-HeFT III investigators. (2000) (10)
- Definition, classification, and staging of the adult cardiomyopathies: a proposal for revision. (2004) (10)
- Reduced atrial natriuretic factor after ligation of the left coronary artery in rats. (1985) (9)
- Cardiovascular and Neurohormonal Effects of Atrial Natriuretic Peptide in Conscious Dogs With and Without Chronic Left Ventricular Dysfunction (1990) (9)
- Arterial vascular compliance response to exercise in hypertension. (1988) (9)
- ACE inhibitors in non-ischaemic heart failure: results from the MEGA trials. (1995) (9)
- Systemic Vascular Resistance (1980) (9)
- ZK 36-374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dog. (1986) (9)
- Heart failure: future treatment approaches. (2000) (9)
- Studies in Clinical Shock and Hypotension: IV. Variations in Reflex Vasoconstriction and Cardiac Stimulation (1966) (9)
- Transdermal nitroglycerin as a step 3 antihypertensive drug (1986) (9)
- The effect of treatment on survival in congestive heart failure (1992) (9)
- Evidence for a direct renal stimulating effect of prostaglandin E2 on renin release in patients with congestive heart failure. (1986) (9)
- Nitric oxide's role in heart failure: pathophysiology and treatment. Introduction. (2003) (9)
- Hemodynamic and metabolic response to nitroprusside infusion in experimental acute myocardial infarction (1973) (9)
- Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III. (1994) (9)
- Current concepts in the treatment of congestive heart failure. (1997) (9)
- New concepts in the mechanisms and treatment of congestive heart failure. Introduction. (1985) (9)
- Is there a common mechanism of benefit for effective treatment of heart failure? (1999) (9)
- Effects of carvedilol on cardiovascular hospitalizations in patients with chronic heart failure (1996) (9)
- III. Antagonist's viewpoint (1988) (8)
- Sympathetic and renin response to orthostasis in congestive heart failure (1980) (8)
- The message is clear: prevent as well as treat acute myocardial infarction. (2013) (8)
- Preventing congestive heart failure. (1998) (8)
- Future directions in vasodilator therapy for heart failure. (1991) (8)
- Is neurohormonal activation deleterious to the long-term outcome of patients with congestive heart failure? III. Antagonist's viewpoint. (1988) (8)
- Beta-blockers in heart failure. (1998) (8)
- Inotropic properties of an isoquinoline derivative (NC 7197) in man (1973) (8)
- Hemodynamic and regional blood flow response to piroximone (MDL 19,205) in dogs with congestive heart failure: a comparison with dobutamine. (1987) (8)
- Ephedrine-nitroprusside combination in congestive heart failure (1978) (8)
- Efficacy of vasodilators in the treatment of heart failure. (1993) (8)
- Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT). (2011) (8)
- Improving outcomes in heart failure. (1998) (8)
- Monitoring adherence to guidelines. (2008) (8)
- Rationale for angiotensin II receptor blocker therapy in chronic heart failure (2000) (8)
- What is the role of angiotensin-receptor blockade in cardiovascular protection? (2006) (8)
- Salvaging the history, physical examination and doctor-patient relationship in a technological cardiology environment. (1999) (8)
- Myocardial infarction shock revisited. (1967) (8)
- N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Biomarker of Cardiac Disease (2005) (7)
- Hemodynamic, Neurohumeral, and Renal Response to Atrial Natriuretic Peptide in Conscious Dogs (1986) (7)
- Prognosis in congestive heart failure. (1996) (7)
- Nervous system control mechanisms in heart failure. (2009) (7)
- Prevention of Heart Failure (1999) (7)
- Angiotensin receptor blockers and clinical trials in heart failure. (2003) (7)
- Localization of Changes inβ-actin Expression in Remodeled Canine Myocardium (1999) (7)
- Left and Right Ventricular Filling Pressures in Clinical Shock. (1968) (7)
- Slowing the progression of heart failure. (1996) (7)
- Drug Treatment of Heart Failure (1988) (7)
- Blood pressure and the therapy of advanced heart failure. (2004) (7)
- Effect of prazosin on renal function in congestive heart failure (1980) (7)
- Systemic and regional hemodynamics after coronary embolization in closed chest dogs (1974) (7)
- OPC-8212 in the treatment of congestive heart failure: Results of a pilot study (1988) (7)
- Physiological variables as markers for symptoms, risk, and interventions in heart failure (1993) (7)
- Nitrates versus angiotensin-converting enzyme inhibitors for congestive heart failure. (1993) (7)
- Statistical significance of Veterans Administration Vasodilator Heart Failure Trial results. (1990) (7)
- Overview of Pathophysiology of Clinical Heart Failure (1994) (7)
- Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure (2003) (6)
- Experience with expedited reviews (2000) (6)
- Quantitative analysis of postmortem changes in myocardial norepinephrine using HPLC with electrochemical detection. (1984) (6)
- Pharmacological manipulation of myocardial metabolism (1974) (6)
- EARTH: EndothelinA Receptor Antagonist Trial in Heart Failure (2001) (6)
- Relation between changes in ejection fraction over time and subsequent mortality and morbidity in Val-HeFT (2003) (6)
- Unloading the failing heart. Previous experience and future directions. (1989) (6)
- Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment. (2002) (6)
- Heart disease in the hypertensive patient. (1977) (6)
- Efficacy of Long-Term Nitrate Treatment in Chronic Left Ventricular Failure (1981) (6)
- Nitrates are effective in the treatment of chronic congestive heart failure: the protagonist's view. (1990) (6)
- Pathophysiology and Clinical Recognition of Heart Failure (2007) (6)
- What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure? (2000) (6)
- 786-4 Cigarette Smoking Inhibits Basal but not Stimulated Release of Nitric Oxide from the Forearm Vasculature (1995) (6)
- Echocardiographic assessment of left ventricular hypertrophy and function in renal hypertensive dogs. (1982) (6)
- Congestive cardiomyopathy: pathophysiology and response to therapy. (1978) (6)
- B059: Small but not large artery compliance predicts cardiovascular events (2000) (6)
- Acute hemodynamic and hormonal response to indoramin in congestive heart failure (1984) (6)
- Early and prolonged antihypertensive effects of the cardioselective beta blocker atenolol (1979) (6)
- Treatment of patients with heart failure. (1990) (6)
- Office Blood Pressure and Cardiovascular Disease: Pathophysiologic Implications for Diagnosis and Treatment. (2017) (5)
- Systemic and regional hemodynamic effects of alpha-adrenoceptor blockade in chronic left ventricular dysfunction in the conscious dog. (1990) (5)
- Effect of nebivolol or atenolol vs. placebo on cardiovascular health in subjects with borderline blood pressure: the EVIDENCE study (2017) (5)
- Pharmacotherapy: Inhibiting LV remodeling—the need for a targeted approach (2011) (5)
- Vasodilator therapy for heart failure: what have we learned from controlled clinical trials? (1988) (5)
- Inotropic therapy for heart failure: paradise lost. (2009) (5)
- Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure (2022) (5)
- Hemodynamic effects of converting enzyme inhibitor in congestive heart failure (1978) (5)
- Use of nitrates in congestive heart failure (1984) (5)
- Different patterns of porta-systemic shunting in cirrhosis of the liver studied by an indicator dilution technique. (1971) (5)
- Effects of ARB-ACEI combination therapy on morbidity and mortality in heart failure (1998) (5)
- Vascular compliance changes in hypertensive dogs during nitroprusside infusion as measured by pulse-contour-analysis. (1987) (5)
- Nitroprusside infusion in acute myocardial infarction. (2009) (5)
- Fixed vs. Non-fixed coronary stenosis: The response to a fall in coronary pressure (1980) (5)
- Site of premature ventricular contractions demonstrated by echocardiography. (1981) (5)
- Vasodilators in congestive heart failure. (1980) (5)
- Nitroprusside and dobutamine effect on myocardial oxygen supply/demand in experimental myocardial infarction (1974) (5)
- Contrasting Degradation Rates of Synthetic Angiotensin Amide and Natural Angiotensin in Human Plasma (1970) (4)
- Vasodilator therapy of dilated cardiomyopathy. (1986) (4)
- Prevention of cardiovascular disease. (2015) (4)
- Early cardiovascular structural and functional abnormalities as a guide to future morbid events. (2021) (4)
- Clinical Experience with Perindopril in Elderly Hypertensive Patients (2004) (4)
- Effects of valsartan on morbidity and mortality in heart failure patients not receiving ACE inhibitors (2002) (4)
- Hemodynamic effects of oxdralazine and hydralazine in hypertension (1980) (4)
- Intent-to-treat: a curse of clinical trials. (1998) (4)
- Pharmacologic mechanisms of nitrates in myocardial ischemia. (1992) (4)
- Techniques for studying arterial elastic properties. (2002) (4)
- Bradycardia with traumatic hyphema in children. (1987) (4)
- Who should treat cardiac failure? (1995) (4)
- Hydralazine and the tourniquet test in renal vein renin sampling: a comparison. (1983) (4)
- Physiological rationale for co-treatment with diuretics in heart failure. (1994) (4)
- Hypertension therapeutic research: a plea for change in the new millennium. (2002) (4)
- A statement and the Journal's philosophy (1994) (4)
- Importance of state of consciousness in determining hemodynamic responses to acute coronary occlusion in the dog. (1977) (4)
- Vasodilator therapy of congestive heart failure. (1980) (4)
- Sequential changes in intrarenal hemodynamics during saline infusion in the dog. (1975) (4)
- VASCULAR COMPLIANCE IN CONGESTIVE HEART FAILURE. (1985) (4)
- Mortality as an endpoint for cardiac failure therapy. (1995) (4)
- Progress at the interface of inflammation and asthma: Report of the ALA/ATS workshop on future directions in asthma research (1995) (4)
- Anti-intellectualism in clinical cardiovascular medicine. (2000) (4)
- Relation to Disease Severity and Prognosis in the Valsartan Heart Failure Trial (2010) (4)
- Is activation of the renin-angiotensin system hazardous to your health? (2011) (4)
- Monitoring Cardiovascular Disease Progression (2019) (4)
- F002: Neurohormonal response to L-NAME infusion in normal subjects (2000) (4)
- Introduction to wave reflection, wave travel and changes with modification of geometric and physical parameters. (1992) (4)
- Overview: Cardiac Remodeling and Its Relationship to the Development of Heart Failure (2005) (4)
- New concepts regarding events that lead to end-stage heart disease (1995) (4)
- Evolution of Abnormalities in Left Ventricular Function After Acute Myocardial Infarction. (1971) (4)
- A-HeFT: old dog, new endothelial tricks. (2005) (4)
- Vasodilator symposium. Introduction: marriage of the heart and the peripheral circulation. (1981) (4)
- Quantitative testing for the cardiac patient: the value of monitoring gas exchange (1987) (4)
- Information vs knowledge. (1996) (4)
- VASOCONSTRICTOR DRUG EFFECTS ON VASCULAR COMPLIANCE BY PULSE CONTOUR ANALYSIS. (1987) (3)
- Current therapy for heart failure (1988) (3)
- Small artery elasticity index but not large artery elasticity index is related to the disease duration in early onset insulin dependent diabetes mellitus (1999) (3)
- Cardiac failure and the autonomic nervous system (2013) (3)
- Early cardiovascular structural and functional abnormalities as a guide to future morbid events. (2020) (3)
- Task force IV: pharmacologic interventions. Emergency cardiac care. (1982) (3)
- Diastolic pressure and peripheral resistance during stellate ganglion stimulation. (1963) (3)
- Rationale for α‐Blockade in Congestive Heart Failure (1986) (3)
- Handbook of Cardiovascular Clinical Trials (1996) (3)
- Arterial compliance to stratify cardiovascular risk (2001) (3)
- Discussion and Debate (1999) (3)
- Nitrate tolerance: Past, present, and future - Discussion sessions (1998) (3)
- Evaluating pathophysiologic processes rather than clinical end points in improving therapeutic practice. (1998) (3)
- Approach to treatment of the patient with heart failure in 1994. (1994) (3)
- Exercise tolerance as a guide to therapeutic efficacy for heart failure : the potential for angiotensin receptor blockers. (1999) (3)
- Beneficial effects of atrioventricular synchrony in dogs with right coronary artery embolization, and complete heart block. (1987) (3)
- Arguments prove nothing unless verified. A commentary on Kaufman's "Epidemiologic analysis of racial/ethnic disparities: some fundamental issues and a cautionary example". (2008) (3)
- Association of quality of life with improved clinical outcomes: results from the valsartan heart failure trial (2002) (3)
- Calcium-entry Blockers in Coronary Artery Disease: Introduction (1982) (3)
- Detecting the patient at risk of heart failure. (2010) (3)
- Calcium Antagonists in Heart Failure (1988) (3)
- Role of neurohumoral control of the circulation in determining exercise capacity in patients with heart failure. (1992) (3)
- Slowing the Progression of Cardiovascular Disease. (2016) (3)
- Vasodilator therapy: implications in acute myocardial infarction and congestive heart failure. (1982) (3)
- Hormones, Drugs, Remodeling and Outcome in Heart Failure and after Myocardial Infarction (2004) (3)
- Factors predicting acute and long-term response to captopril therapy in congestive heart failure. (1982) (3)
- Comparison of the colloidal chromic phosphate and BSP clearance methods for estimating hepatic blood flow. (1962) (3)
- Chronobiologic blood pressure and heart rate assessment of patients with heart transplants. (1990) (3)
- Stimulation by vasodilators of the (Na+K) ATPase of vascular smooth muscle (1973) (3)
- Relationships of acute captopril effect in heart failure on renin and sympathetic mechanisms (1980) (3)
- Hemoglobinuria after massive intraperitoneal hemorrhage. (1959) (3)
- Renal vein renin sampling in essential hypertension using hydralazine and the tourniquet test. (1984) (2)
- The Medical Management of Heart Failure (2007) (2)
- Global structural ventricular remodeling: summation. (2002) (2)
- Optimizing antianginal therapy: consensus guidelines. (1992) (2)
- Evaluation of early myocardial ischemia with thallium-201 in the pig. (1977) (2)
- Rapid pacing heart failure. (1992) (2)
- Hepatocirculatory failure. (1975) (2)
- Cutaneous administration of nitroglycerin (1983) (2)
- Dissociation of inotropic from chronotropic effects of isoproterenol during beta blockade with labetalol (Sch 15719W) (1976) (2)
- The joy of discovery. (1997) (2)
- Beta-blockers for heart failure. (2003) (2)
- Effect of valsartan on time-adjusted and hospitalization frequency rate in the valsartan heart failure trial (2002) (2)
- The nuclear stethoscope. (1985) (2)
- B-type natriuretic peptide and artery stiffness. (2006) (2)
- Nitrates in Left Ventricular Dysfunction and Congestive Heart Failure (1998) (2)
- Preventing heart failure: a critique of strategies. (2013) (2)
- Course of arterial and pulmonary wedge pressures after acute myocardial infarction: Effect of nitroprusside (1978) (2)
- Aortic regurgitation associated with ventricular septal defect. Echocardiographic and hemodynamic observations. (1977) (2)
- Review: increased waist circumference or waist-to-hip ratio is associated with increased risk of cardiovascular events (2007) (2)
- Measuring endothelial dysfunction. (2007) (2)
- B-type natriuretic peptide level had reduced specificity for diagnosing heart failure in dyspnea with atrial fibrillation in the emergency department. (2006) (2)
- Treatment of infarct related heart failure: Vasodilators other than ACE inhibitors (1994) (2)
- Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT. (2006) (2)
- Should the blood pressure or the blood vessel be the target of therapy? (2011) (2)
- Effect of captopril on renal function in congestive heart failure (1980) (2)
- Val-HeFT: changing the heart failure horizon (2003) (2)
- Localization of changes in beta-actin expression in remodeled canine myocardium. (1999) (2)
- Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease (2021) (2)
- Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine Inhibits Left Ventricular Remodeling in Well-Treated Severe Heart Failure in African-Americans: A-HeFT (2005) (2)
- Addressing the heart failure management gap. (1999) (2)
- P4542Revisiting the obesity paradox in heart failure: percent body fat as predictor of biomarkers and outcome (2019) (2)
- Vasodilators in Heart Failure (2012) (2)
- Hepatocirculatory failure: Diverse pathogeneses deserve diverse therapies (1990) (2)
- The mysterious angiotensin-converting enzyme inhibitors. (1997) (2)
- Lack of acute effects of nitrates on exercise capacity in congestive heart failure (1978) (2)
- Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting. (1996) (2)
- CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IS A COMMON COMORBIDITY AND IS INDEPENDENTLY ASSOCIATED WITH ADVERSE OUTCOMES IN AFRICAN-AMERICAN PATIENTS WITH HEART FAILURE (2013) (2)
- P-342: Supranormal ankle brachial index is associated with a favorable exercise blood pressure response (2003) (2)
- Hypokalemia with normal blood pressure preceding malignant hypertension in a patient with primary aldosteronism (Conn's syndrome). (1972) (2)
- From Hypertension to Heart Failure (1998) (2)
- New strategies in cardiovascular disease management: Summary of round table discussion (1997) (2)
- Fractional flow reserve–guided PCI reduced urgent revascularization at 7 months in coronary artery disease (2012) (2)
- Plasma arginine vasopressin in hyponatremic patients with heart failure. (1981) (2)
- ACE inhibitors (2004) (2)
- Pathophysiological considerations in selecting vasodilator therapy for CHF. (2009) (2)
- Pharmacologic Management of Heart Failure in the Ambulatory Setting (2007) (2)
- Treatment by Modification of Circulatory Dynamics (1984) (2)
- 1163-114 Prognostic role of plasma C-reactive protein in heart failure: Results from Val-HeFT (2004) (1)
- Left and right ventricular pressure diameter relationships during ventricular standstill in the dog. (1982) (1)
- Carvedilol reduced mortality and hospitalization in chronic heart failure (1996) (1)
- Are arterial stiffness and micro-albuminuria in pre-hypertensives different from normotensives and hypertensives? (2004) (1)
- Early Redistribution of Thallium201 Thallium201 Thallium201 after Temporary Ischemia (2005) (1)
- 1163-121 Prognostic role of neutrophil and lymphocyte counts in heart failure: Results from Val-HeFT (2004) (1)
- The predictive value of combinations of different levels of brain natriuretic peptide and norepinephrine in the Val-HeFT trial (2002) (1)
- Contribution of ACE inhibition to the management of heart failure: Introduction (1993) (1)
- Effect ofcaptopril onrenal function inpatients with congestive heart failure (1981) (1)
- Effect of Systemic Vasoconstriction on Left Ventricular Function: Implications Regarding Hypertension and Heart Failure (1981) (1)
- Non-invasive pulse contour analysis in the assessment of capacitive and oscillatory arterial compliance. (1995) (1)
- A symposium: from hypertension to heart failure: endothelial dysfunction and structural changes in cardiovascular disease. Introduction. (1995) (1)
- The President’s Page: Target Response or Target Dose (2009) (1)
- Trials and Tribulations. (2016) (1)
- Sequential neurohormonal response to felodipine in enalapril-treated heart failure: V-HeFT III (1996) (1)
- 41 Circulating levels and prognostic cut-offs of sST2, high-sensitivity troponin T, and NT-proBNP in women vs. men with chronic heart failure (2021) (1)
- The sympathetic response to exercise in patients with congestive heart failure (1981) (1)
- Left ventricular mass and volume after myocardial infarction. (1993) (1)
- Hyponatraemia asamarker forhighrenin heart failure (1982) (1)
- Left ventricular dysfunction and heart failure. Mechanistic and therapeutic distinctions. (1996) (1)
- Chapter 12 – Pharmacologic Management of Heart Failure in the Ambulatory Setting (2013) (1)
- Heart Failure with Recovered Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival. Results from Val-HeFT (2016) (1)
- Review: concomitant aspirin use does not reduce the effectiveness of ACE inhibitors. (2003) (1)
- Mechanism of the hepatojugular reflux test (1970) (1)
- Review: Antihypertensive treatment prevents cardiovascular events and mortality in cardiovascular disease without hypertension (2011) (1)
- No baseline for blood pressure in ordinary life: another case of transient chronome alterations. (2004) (1)
- Preload reduction vs vasodilators in heart failure (1976) (1)
- Medical Treatment of Heart Failure: Problems in Dilated Cardiomyopathy (1998) (1)
- Prognostic Indicators and Assessment of Therapeutic Responses (2002) (1)
- Clinical Research: Whose Agenda Is It? (2004) (1)
- The V-HeFT Study (2005) (1)
- Left Ventricular Function After Myocardial Infarction (1989) (1)
- Reduction In body weight is an independent risk factor for mortality in chronic heart failure. Insights from GISSI-HF and Val-HeFT trials (2013) (1)
- P-596: Valsartan increases small arterial elasticity in asymptomatic individuals (2005) (1)
- Has the problem of heart failure been solved? (1994) (1)
- Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators. (1996) (1)
- A retrospective analysis of major determinants of heart failure mortality in patients receiving both ACE inhibitors and Beta-blockers in Val-HeFT (2003) (1)
- Arterial Elasticity/Stiffness (2011) (1)
- E10 Determinant factors of the proximal and distal arterial compliance in normo- to hypertensive blood pressure range (1997) (1)
- In vivo interaction of AR-L 115BS (Vardax) with the adrenergic nervous system. (1984) (1)
- Verification of the modified Windkessel model of the arterial vasculature (1992) (1)
- Inotropism without chronotropism in response to isoproterenol after combined beta and alpha adrenergic blockade in man (1976) (1)
- Valsartan attenuates heart failure progression (2002) (1)
- Cardiac resynchronization therapy is effective in patients with atrial fibrillation: interim results from the RESTORE-U.S. study (2004) (1)
- Effects of MK 421, a long acting oral converting enzyme inhibitor, on hemodynamics and regional blood flow in heart failure (1982) (1)
- An explanation for varying views about digitalis efficacy in congestive heart failure (2005) (1)
- The Clinical Context of Vascular Compliance: Compromised Vascular Compliance as a Measure of Cardiovascular Risk (1999) (1)
- Is the additive hemodynamic effect of valsartan in angiotensin converting enzyme inhibitor treated patients related to inadequate background angiotensin converting enzyme inhibitor usage (1999) (1)
- Queries and Minor Notes: Then and Now: DIGITALIS IN HEART FAILURE (1984) (1)
- Hemodynamic consequences of prostaglandin E2 activation of the renin-angiotensin system in heart failure. (1987) (1)
- Clinical Investigations Relationship of Quality of Life Scores With Baseline Characteristics and Outcomes in the African-American Heart Failure Trial (2009) (1)
- Haemodynamic Effects of β-Blockers (2012) (1)
- Conjugated plasma norepinephrine in patients with congestive heart failure (1982) (1)
- Abnormalities in Ventricular Function following MI: The authors reply (1973) (1)
- Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine Improves Outcomes in Elderly Heart Failure Patients in the African-American Heart Failure Trial (2007) (1)
- Contrasting arterial compliance effects of enalapril and amlodipine in normotensive elderly subjects (1999) (1)
- Neurohumoral and hemodynamic response to bromocriptine in patients with congestive heart failure (1982) (1)
- Eclecticism in a passionate profession. (1983) (1)
- Human cardiac transplantation at the University of Minnesota. (1984) (1)
- Noninvasive cardiopulmonary monitoring. (1981) (1)
- Wednesday May 28, Ballroom A, 6:00 am The Role of Angiotensin II in Cardiovascular Disease: Additive effects of AT1 receptor blockade with valsartan and ace inhibition in patients with heart failure (1997) (1)
- Circulation and hemodynamics. (1994) (1)
- 1032-121 Utility of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy (2004) (1)
- Changes in plasma brain natriuretic peptide and norepinephrine over time and subsequent mortality and morbidity in heart failure: Results from Val-HeFT (2003) (1)
- Stage B, a pre-cursor of heart failure. (2012) (1)
- BNP AS A MARKER FOR LEFT VENTRICULAR HYPERTROPHY IN ASYMPTOMATIC, NORMOTENSIVE INDIVIDUALS (2014) (1)
- Abstract 18594: Plasma Volume Status Calculated Instantaneously from Weight and Hematocrit Relates to Objectively Measured Plasma Volumes and Powerfully Predicts Death and First Morbid Events in Chronic Heart Failure (2012) (1)
- Friday May 30, Ballroom B and C, 5:00 pm Theme III: Hypertension and Congestive Heart Failure: Hypertension, vascular and cardiac structure, and heart failure (1997) (1)
- Hypertension in practice (1987) (0)
- 1108-118 Comparative yield of clinical, laboratory, echocardiographic, and neurohormonal predictors of outcome in heart failure patients (Val-HeFT data) (2004) (0)
- Guidelines for discontinuation of digitalis therapy (1976) (0)
- Abstract 2642: Ventricular Tachycardia in the African-American Heart Failure Trial (2007) (0)
- Treatment of shock following myocardial infarction. (1969) (0)
- Arterial stiffness. (1999) (0)
- Prevention of heart failure. (1999) (0)
- Converting Enzyme Inhibitors in the Treatment of Heart Failure (1981) (0)
- Seventy‐eighth Annual Meeting, March 23, 24, and 25, 1977 Fairmont Hotel, Dallas, Texas (1977) (0)
- Determining the Serum Concentration Alone Is Not Sufficient to Justify Potassium Administration—Reply (2001) (0)
- Cardiovascular morbidity was better predicted by ambulatory rather than office pulse pressure (1999) (0)
- The design of V-HEFT II: Rerandomization of V-HEFT I survivors (1986) (0)
- Vasodilators in Acute Myocardial Infarction (1984) (0)
- Rationale for alpha-blockade in congestive heart failure. (1986) (0)
- Contents Vol. 1, 2001 (2001) (0)
- Status of Vasodilators for Heart Failure (1987) (0)
- The James B. Herrick Award Lecture. 2003. Clinical research: whose agenda is it? (2004) (0)
- Ambulatory blood pressure is related to proximal arterial compliance and regional large artery compliance, but not to the small-sized artery compliance (1997) (0)
- Congestive heart failure: Is the heart or periphery at fault? (1987) (0)
- Treatment of shock following myocardial infarction. (1969) (0)
- Vasodilator Therapy of Heart Failure: influence of prerandomization variables (2005) (0)
- Clinical Data at the Time of Study in 17 Patients With Shock Blood Urine Age BSA pressure output BUN * Patient Diagnosis (0)
- 444 C-Reactive protein in 4202 patients with moderate to severe heart failure in Val-HeFT (2004) (0)
- Assessment of vasodilatation in man. (1984) (0)
- HEPATORENAL FAILURE FOLLOWING PORTACAVAL SHUNT: HEMODYNAMIC CONSIDERATIONS AND THE APPLICATION OF ASCITIC FLUID INFUSION. REPORT OF A CASE. (1964) (0)
- A patient with severe congestive heart failure: Intensive medical management (1983) (0)
- P-9: Exercise blood pressure response is inversely related to large artery, but not to small artery elasticity (2005) (0)
- MY APPROACH to the patient with heart failure and improved ejection fraction⁎. (2018) (0)
- Manuscript review process (1998) (0)
- VASCULAR IMPEDANCE BY PULSE CONTOUR/WINDKESSEL ANALYSIS (PCWA). (1984) (0)
- Efficacy of isosorbide mononitrate in angina pectoris. Discussion (1992) (0)
- Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT (2003) (0)
- Reducing ventricular remodeling key to interrupting HF progression (2003) (0)
- Effects of valsartan on left ventricular ejection fraction and diastolic diameter in patients with heart failure: Val-HeFT echocardiographic study (2002) (0)
- Comprar Stage B, a Pre-cursor of Heart Failure, An Issue of Heart Failure Clinics | Jay N. Cohn | 9781455738717 | Saunders (2012) (0)
- Risk Factors (Lipids) (2008) (0)
- Efficacy and safety in clinical trials. Authors' reply (2007) (0)
- 238 Brain natriuretic peptide (BNP) and symptoms as markers of a therapeutic response in chronic heart failure: Val‐HeFT substudy (2004) (0)
- 958-94 Neurohormonal and Hemodynamic Effects of SDZ WAG 994 a Novel Selective A1Adenosine-receptor Agonist in Patients with Heart Failure (1995) (0)
- B022: Large artery but not small artery elasticity index is increased in athletic sports men versus control subjects (2000) (0)
- Possible mechanisms of nitrate tolerance. Discussion (1992) (0)
- The hemodynamic response to valsartan in angiotensin converting enzyme inhibitor treated patients: Influence of baseline norepinephrine levels and valsartan dose (1999) (0)
- EARLY CARDIOVASCULAR FUNCTIONAL AND STRUCTURAL ABNORMALITIES SCORE IN ASYMPTOMATIC ADULTS AS A GUIDE TO MAJOR ADVERSE CARDIOVASCULAR EVENTS (2023) (0)
- New concepts for why beta-blockers are helpful in heart failure (2004) (0)
- Cardiovascular Pharmacotherapy 2010 (2010) (0)
- P-315: C-reactive protein is related to an increased blood pressure response during exercise in a primary prevention population (2004) (0)
- INDICATIONS FOR DIGITALIS THERAPY. A NEW LOOK (1975) (0)
- SNPS IN NOS3 ARE ASSOCIATED WITH A CARDIOVASCULAR DISEASE SCORE IN ASYMPTOMATIC INDIVIDUALS (2011) (0)
- Introduction (1993) (0)
- Foreword (1964) (0)
- ldosterone Synthase Promoter olymorphism Predicts Outcome in frican Americans With Heart Failure esults From the A-HeFT Trial (2006) (0)
- Ca2-Receptor-Mediated Vasoconstriction in Patients With Congestive Heart Failure (2005) (0)
- General Cardiology: Hypertension, Prevention and Lipids16. HypertensionDNA VARIANTS IN NOS3 ARE ASSOCIATED WITH IMPROVED SMALL ARTERY ELASTICITY AND DECREASED SYSTOLIC BLOOD PRESSURE IN ASYMPTOMATIC INDIVIDUALS (2011) (0)
- Abnormal Left Ventricular Filling in Patients with Concentric Hypertrophy on Chronic Hemodialysis (1978) (0)
- 1069-107 Hospitalizations in heart failure: It's not what you think (2004) (0)
- Relationship between 24 hr ambulatory blood pressure and large arteries compliance (1997) (0)
- Looking back and looking forward. (2001) (0)
- Industry, academia, and postgraduate education. (1997) (0)
- P-523: Leptin is associated with insulin resistance and impaired small artery distensibility in subjects with high normal blood pressure (2002) (0)
- Introduction (1995) (0)
- Editorial: Vasodilator therapy of myocardial infarction. (1974) (0)
- K022 The carotid artery intima-media thickness is related to the distal arterial compliance but not to the proximal arterial compliance (1998) (0)
- VASCULAR IMPEDANCE METHODOLOGY IN CONGESTIVE HEART FAILURE. (1982) (0)
- How can clinical studies and large-scale intervention trials help optimise individually targeted therapy (1997) (0)
- The acute effects of nitroprusside on plasma norepinephrine, renin activity, and arginine vasopressin in patients with congestive heart failure (1982) (0)
- Abstract 2739: Effect of Angiotensin Converting Enzyme Inhibitor or Beta-Blocker Use on the Benefit of Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial (2006) (0)
- Early Experience with Captopril in Congestive Heart Failure (1983) (0)
- CONGESTIVE HEART FAILURE Evidence for a direct renal stimulating elfect of prostaglandin E 2 on renin release in patients with congestive heart failure (2005) (0)
- Response of vasopressin to increased central venous and arterial pressure in normal man (1982) (0)
- Prognostic Value of Aldosterone in Heart Failure – Results from Val-HeFT (2003) (0)
- Heart Failure is Preventable (2010) (0)
- Stage B, a precursor of heart failure, part II. (2012) (0)
- Whose Agenda Is It ? (2004) (0)
- P-498: Role of gender on the relationship between Brain-Natriuretic Peptide (BNP) and left ventricular dimensions (2005) (0)
- 3381Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes (2018) (0)
- Cardiac Structure and Function (2007) (0)
- 302: Progressive Decrease in Large and Small Artery Elasticity With the Presence of Multiple Components of the Metabolic Syndrome (2007) (0)
- Vasoactive Drugs and the Failing Ventricle (1985) (0)
- Treatment of shock following myocardial infarction. (1969) (0)
- Contribution of ACE inhibition to the management of heart failure : proceedings of a symposium held in New Orleans, Louisianna, on November 19, 1992, on the occasion of the 65th Annual Scientific Sessions of the American Heart Association (1993) (0)
- Clinical pharmacology of organic nitrates. Discussion (1993) (0)
- Pharmacologic Principles in the Use of New Inotropic Agents (1983) (0)
- Cardiovascular Medicine + DVD (2007) (0)
- Journal of cardiac failure: Editorial (2001) (0)
- 1142-182 Differences in brain-natriuretic peptide and left ventricular dimensions and mass in normotension, prehypertension and hypertension (2004) (0)
- Letter from Jay N. Cohn to Edward D. Freis (1987) (0)
- Symposium reporter 2003. New therapeutic options in the management of hypertension to heart failure. Orlando, Florida, USA, March 6, 2003. (2003) (0)
- What Vascular Effects Should be Measured in Antihypertensive Drug Research (1990) (0)
- Treatment of shock following myocardial infarction. (1969) (0)
- Sudden Death as an End-Point for the Clinical Evaluation of Antiarrhythmic Drugs (1985) (0)
- VASCULAR EFFECTS OF VASODILATOR DRUGS: RESISTANCE, COMPLIANCE AND CAPACITANCE : PROGRESS IN ANTI-HYPERTENSIVE VASODILATIVE THERAPY (1989) (0)
- Innovation and clinical practice in an era of polypharmacy for heart failure. (1999) (0)
- American Society of Hypertension, Inc In Memorium: Dr Louis Tobian (2006) (0)
- Evaluation of early myocardial ischemia with /sup 201/Tl in the pig (1977) (0)
- Abstract 2999: Gender-Difference in Brain-Natriuretic Peptide (BNP) Reflects Different Cardiac Remodeling (2006) (0)
- Val‐HeFT‐valsartan in heart failure trial — Gender differences and similarities (2000) (0)
- General Principles of Treatment with Vasodilators (1981) (0)
- Determinants of proximal and distal arterial compliance in normotension and hypertension (1997) (0)
- Neurohormonal Activation and the Management of Heart Failure (2017) (0)
- Florea and Cohn Autonomic Nervous System and Heart Failure 1817 (2014) (0)
- The dilated left ventricle Mechanisms, clinical significance and therapeutic strategy (1994) (0)
- Arterial Structure and Compliance (2007) (0)
- Treatment of shock following myocardial infarction. (1969) (0)
- Effect of Angiotensin Converting Enzyme Inhibitor or Beta-Blocker Use on the Benefit of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial (2006) (0)
- Summary (1964) (0)
- Treatment of shock following myocardial infarction. (1969) (0)
- The clinical context of vascular compliance (1999) (0)
- Concluding Remarks (1984) (0)
- ASSOCATED WITH CONGESTIVE HEART FAILURE USNG HYDRALAZINE AND ISOSORBDE DINTRATE (2017) (0)
- Therapies for heart failure: A glimpse into the future (1996) (0)
- Efficacy and Safety in Clinical Trials Clinical Implications of the PROTECT–TIMI-30 Trial (2007) (0)
- 420 Circ Heart Fail May 2014 Methods Study Design and Patients Selection The Valsartan Heart Failure (0)
- The role of the adrenergic system in heart failure: Introduction (1990) (0)
- Prognosis of congestive heart failure: An overview (1987) (0)
- Hemodynamic and Clinical Effects of Dextran in Nonhemorrhagic Shock in Man. (1965) (0)
- COMBINATION OF ISOSORBIDE DINITRATE AND HYDRALAZINE REDUCES 30 DAY HOSPITAL READMISSIONS AND INCREASES TIME TO HOSPITAL READMISSION IN BLACKS WITH HEART FAILURE (2012) (0)
- SEX DIFFERENCES IN PLASMA CONCENTRATIONS AND PROGNOSTIC VALUE OF NT-PROBNP IN CHRONIC HEART FAILURE (2019) (0)
- Exercise-induced fall in flow through stenotic coronary arteries (1982) (0)
- In memorium louis tobian. (2007) (0)
- Relationship between non-invasive proximal and distal compliance and 24 hours ambulatory blood pressure profile. (1997) (0)
- Hemodynamic effects and elimination of infused norepinephrine in patients with congestive heart failure (1982) (0)
- Cardiac and regional vascular effects of atrial natriuretic peptide in awake dogs with left ventricular dysfunction. (1986) (0)
- Composition pharmaceutique comportant du valsartan (2004) (0)
- Abstract 3147: Characteristics and Prognosis of African American Patients with Atrial Fibrillation in the African American Heart Failure Trial (2007) (0)
- Device for measuring the impedance of blood vessels (1991) (0)
- DNA Variants in NOS3 Are Associated with Improved Small Artery Elasticity and Decreased Systolic Blood Pressure in Asymptomatic Individuals (2011) (0)
- Left Ventricle and Arteries (2001) (0)
- Do we need new cardiovascular disease risk factors (2009) (0)
- Short-term systemic hemodynamic adaptation to antihypertensive therapy with atenolol (1979) (0)
- P-24: Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 899 hypertensive patients on oral hypoglycemic agents - subgroup analysis of a 12-week, open-label, aceon® Community Trial (ACT) (2002) (0)
- The AJC in March 1960 (1985) (0)
- Treatment of shock following myocardial infarction. (1970) (0)
- The surrogate specialist: essential but inadequate. (2001) (0)
- Abstract 2917: BNP Predicts Event-Free Survival in African American Patients with Moderate to Severe Heart Failure but does not Identify Responders to Fixed-dose Combination of Isosorbide Dinitrate / Hydralazine (2007) (0)
- Can Vasodilator Treatment Improve Life Expectancy and Physical Performance Heart Failure (1983) (0)
- Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. (2010) (0)
- The Problem With Cardiovascular Disease Prevention Guidelines (2012) (0)
- P-524: A strategy for early detection of cardiovascular disease with a non-invasive testing array (2002) (0)
- Small artery stiffness, endothelial dysfunction and vascular disease (1996) (0)
- Clinical Trials Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial (2012) (0)
- Journal of cardiac failure: Introduction (2002) (0)
- Interventions to Slow the Progression of Heart Failure (2005) (0)
- Small artery elasticity index is positively related to ankle/brachial index in peripheral arterial occlusive disease (1999) (0)
- Management of potential conflict of interest during publication and presentation. (2001) (0)
- Abstract 2687: A Watchful Waiting Behavior is Advisable Before Implanting an ICD in Patients with Chronic Heart Failure (2006) (0)
- Abstract 2386: Growth-Differentiation Factor-15 is a Strong Predictor of Adverse Outcomes in Heart Failure: Results from Val-HeFT. (2007) (0)
- Elevated brain natriuretic peptide levels are related to impaired small artery elasticity (2003) (0)
- Adrenergic mechanism of femoral arterial constriction during carotid occlusion in dogs. (1987) (0)
- EARLY CARDIOVASCULAR FUNCTIONAL AND STRUCTURAL ABNORMALITIES SCORE IN ASYMPTOMATIC ADULTS AS A GUIDE TO ALL-CAUSE MORTALITY (2022) (0)
- Lumpers versus splitters. (2000) (0)
- LEFT VENTRICULAR MASS AND VOLUME AFTER MYOCARDIAL INFARCTION. AUTHORS' REPLY (1993) (0)
- Improved renal function with hydralazine in patients with congestive heart failure (1979) (0)
- Influence of age and race on the hemodynamic effects of combination angiotensin converting enzyme inhibitor-valsartan therapy (1999) (0)
- Antihypertensive Utility of Perindopril in a Large, General Practice‐Based Clinical Trial (2005) (0)
- The relationship between B-type natriuretic peptide, heart structure, and function in 4,300 patients with heart failure enrolled to Val-HeFT (2003) (0)
- OR-32: Clinical experience with perindopril, an angiotensin converting enzyme inhibitor (ACEI), in U.S. hypertensive patients - a large community-based trial (2003) (0)
- B029: Intravenous infusion of L-NAME does not alter brachial artery area or compliance (2000) (0)
- P3515Gender differences in plasma levels and prognostic value of NT-proBNP in chronic heart failure (2019) (0)
- Does the angiotensin receptor blocker telmisartan prevent morbid atherosclerotic events? (2008) (0)
- VI. RELATIONSHIP BETWEEN LEFT AND RIGHT VENTRICULAR FUNCTION (2016) (0)
- Cardiac failure XIV. Treatment by modification of circulatory dynamics. (1984) (0)
- INTERACTION BETWEEN BASELINE AND EARLY WORSENING OF RENAL FUNCTION AND EFFICACY OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKADE IN PATIENTS WITH HEART FAILURE: INSIGHTS FROM VALSARTAN IN HEART FAILURE TRIAL (2013) (0)
- Beyond the Cuff Using Arterial Elasticity Indices in the Early Assessment and Management of Cardiovascular Disease (2005) (0)
- Treatment of shock following myocardial infarction. (1969) (0)
- THE ACCURACY OF HR1 IN THE ESTIMATION OF LEFT VENTRICULAR MASS IN DOGS WITH HEARTS DISTORTED BY LOCALIZED MYOCARDIAL NECROSIS (1991) (0)
- What's in a name? (2012) (0)
- Vasodilator Therapy for Cardiomyopathy (1990) (0)
- Changes in the finger artery compliance and elasticity as a function of temperature (1992) (0)
- Editor's Note (2001) (0)
- Nitroprusside in acute congestive heart failure. (1977) (0)
- 2010 ASH Faculty (2010) (0)
- CARDIAC FAILURE EDITOR-IN-CHIEF (2009) (0)
- An Interdisciplinary Comparison of Consultation Outcomes (2017) (0)
- P-379: Blood pressure response to angiotensin receptor blockade in the valsartan heart failure trial (Val-HeFT) (2002) (0)
- JAMA Cardiology List of Peer Reviewers. (2017) (0)
- Abstract of papers to be Presented at the 29th Annual Scientific Session of the American College of Cardiology Houston, Texas, March 9 to 13, 1980Decreased shunt flow in acute ventricular septal defect using 15-methyl-prostaglandin F2α as a pulmonary constrictor (1980) (0)
- Azotemia in patients with congestive heart failure treated with captopril. (1983) (0)
- Atrial natriuretic peptide in myocardial infarction. Reply (1987) (0)
- Update on cardiovascular disease: Recent findings and newest therapeutic choices. Introduction (2000) (0)
- Final Panel Discussion (1999) (0)
- 1030-8 Changes in β-Actin mRNA Expression in a Canine Model of Left Ventricular Remodeling (1995) (0)
- Efficacy and safety in clinical trials. (2007) (0)
- 487 Signs and symptoms and relevance to remodeling in chronic heart failure: Val‐HeFT data (2003) (0)
- ACUTE MYOCARDIAL INFARCTION: REACTION AND RECOVERY (1978) (0)
- Which type of blood pressure is best related to arterial elastic behaviour of large and small-sized arteries ? (1997) (0)
- VASCULAR IMPEDENCE IN HEALTH, HYPERTENSION, HEART FAILURE. (1983) (0)
- Biostatistics Versus Pathophysiology. (2021) (0)
- Treatment of shock. (1966) (0)
- Is blood pressure a reliable marker for cardiovascular disease (2014) (0)
- ISCP President’s Page (2009) (0)
- CHRONIC VASODILATOR THERAPY IN THE MANAGEMENT OF CARDIOGENIC SHOCK AND INTRACTABLE LEFT VENTRICULAR FAILURE (1975) (0)
- President’s Page: ISCP’s Educational Goals (2010) (0)
- 304: The Heterogeneous Influence of Metabolic Risk Factors on Arterial Elasticity (2007) (0)
- Abstract 6057: Elevated LDL-Cholesterol Causes a Higher Exercise Blood Pressure Response (2008) (0)
- SYSTEM IN CONGESTIVE HEART FAILURE (1986) (0)
- Discussion—Session III, part I (1981) (0)
- Disease Prevention in Heart Failure (2011) (0)
- The Advisory Committees, Industry, and the Food and Drug Administration (1986) (0)
- Clinical trials: Heart failure treatment — clinical trials versus clinical practice (2016) (0)
- Nitric oxide role in heart failure: Pathophysiology and treatment. Discussion (2003) (0)
- Treatment of shock following myocardial infarction. (1970) (0)
- Vasodilator effects on vascular impedance characteristics (1979) (0)
- Abstract 14419: Effect of Nebivolol or Atenolol versus Placebo on Cardiovascular Health in Subjects With Borderline Blood Pressure: The EVIDENCE Study (2016) (0)
- Abstract 2744: Sex Differences in Heart Failure with Systolic Dysfunction: A Pooled Analysis of Five Randomized Control Trials (2006) (0)
- Management of Heart Failure (1991) (0)
- Role of drugs for systemic hypertension and their effect on the heart. (1987) (0)
- Abstract 2452: Presence of Early Cardiovascular Disease Markers within the Range of Prehypertension vs Normotension and Hypertension (2008) (0)
- CorrespondenceLetters to the EditorInfluence of pretreatment systolic blood pressure on benefit from carvedilol in severe chronic heart failure patients: Reply (2005) (0)
- 873-5 Systolic reflective index: A new parameter to study arterial elasticity (2004) (0)
- What does ATLAS really tell us about [ldquo ]high[rdquo ] dose angiotensin-converting enzyme inhibition in heart failure? (2000) (0)
- Comprar Cardiovascular Medicine + DVD | Jay N. Cohn | 9781846281884 | Springer (2007) (0)
- Effect of estrogens on vascular compliance in postmenopausal women: P-77. (1995) (0)
- Valsartan produces a sustained decrease in plasma aldosterone independent of age, gender, or race: Results from Val-HeFT (2003) (0)
- Left ventricular remodeling and neurohormonal stimulation as markers for mortality and response to therapy in heart failure (1995) (0)
- The Paradox in Demonstrating Hydralazine-Nitrate Efficacy. (2017) (0)
- Importance of Alpha Blocking and Vasodilator Effects of Beta Blocking Agents (1982) (0)
- Val‐HeFT‐valsartan in heart failure trial: A comparison of patients based on left ventricular ejection fraction (2000) (0)
- Conflicts of interest: to eliminate them or manage them. (2009) (0)
- President’s Page: Beijing 2009 (2009) (0)
- Relationship between Changes in Ejection Fraction, BNP and Norepinephrine over Time and the Effect of Valsartan in Val-HeFT (2003) (0)
- Subject Index Vol. 1, 2001 (2001) (0)
- Nitric oxide role in heart failure: Pathophysiology and treatment. Discussion (2003) (0)
- Reduced arterial vascular compliance as a marker for essential hypertension (1990) (0)
- The Journal thanks the following consultants who, in addition to the members of the Editorial Board, gave their time to review manuscripts submitted in 1980. (1980) (0)
- GEORGE A . BROWN MEMORIAL LECTURE Carotid and Aortic Regulation of Arterial Blood Pressure (2005) (0)
- HOPE for an ACE inhibitor. (1999) (0)
- Abstract P147: Office Blood Pressure: An Inadequate Guide to the Diagnosis and Treatment of Hypertension (2015) (0)
- Pharmacologic mechanisms of nitrates in myocardial ischemia. Discussion (1992) (0)
- OP-005 CVD RISK ASSESSMENT IN MALE POPULATION BEYOND FRAMINGHAM (2010) (0)
- Complicated myocardial infarction with chronic pulmonary disease. Problems in management. (1979) (0)
- The proper use of calcium channel blockers (1996) (0)
- OR-11: CRP is associated with increased large artery stiffness in a primary prevention population (2003) (0)
- Some Thoughts from Your Publisher (2001) (0)
- Bradycardia with Mitral Valve Prolapse (2020) (0)
- SL1 Progression of Cardiovascular Disease: A New Therapeutic Target (2009) (0)
- 723-4 Cardiovascular and Neurohormonal Effects of SDZ WAG 994, a Selective Adenosine A1Receptor Agonist, in Man (1995) (0)
- Determinant factors of the proximal and distal arterial compliance (1997) (0)
- Noninvasive pulse contour analysis associated with microalbuminuria (2003) (0)
- Nitrates and angina pectoris. Discussion (1993) (0)
- STUDIES IN CLINICAL SHOCK AND HYPOTENSION. II. HEMODYNAMIC EFFECTS OF NOREPINEPHRINE AND ANGIOTENSIN (1966) (0)
- Efficacy of short term oral administration of a new inotropic drug (Esproquin) in congestive heart failure (1973) (0)
- Vascular compliance in heart failure: A contributor to impedance, and the response to vasodilator drugs (1991) (0)
- A REVIEW OFTHEHAEMODYNAMIC EFFECTSOFLABETALOL INMAN (1982) (0)
- Echocardiographic and Hemodynamk Observations (2017) (0)
- Lipids, blood pressure and early cardiovascular disease, need for revisit (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jay Norman Cohn?
Jay Norman Cohn is affiliated with the following schools:
